According to a recent market study published by Growth Market Reports, titled, “Global Blood Bank Management Software Market by Type, by Deployment Mode, by End-User, by Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 602.19 Million in 2022 and is expected to grow at a moderate growth rate of 5.2% by the year 2031.

As per Growth Market Reports industry analyst Akash Vedpathak, “Global Blood Bank Management Software Market is anticipated to witness significant growth during the forecast period 2023-2031.

The software maintains a database of donors and their eligibility criteria. It schedules blood donation appointments and tracks donor information, such as blood type, donation history, and contact details. The software monitors blood inventory levels, tracks the expiration dates of blood products, and ensures that the appropriate blood products are available for transfusions.

Get Sample Report @ https://growthmarketreports.com/request-sample/5766

The software provides data analytics and reporting functions, allowing for the tracking of key performance indicators (KPIs), such as donor recruitment, inventory levels, and blood usage.

Blood bank management software needs to coordinate with other healthcare frameworks, such as electronic health records (EHRs), laboratory information management systems (LIMS), or hospital information systems (HIS).

Supply chain management is an essential part of any business. A supply chain contains a series of steps to get products from their original state to the customers. The Blood Bank Management Software Market has a complex supply chain that involves a variety of suppliers and service providers. The market of Blood Bank Management Software includes Suppliers, Software Development, Distribution, Implementation and Integration, Training and Support, Maintenance and Upgrades, and End Users.

The primary, as well as secondary research methodology, is used for keen observation and study of the Blood Bank Management Software Market. The primary research methodology involves commercial agreements made with the primary respondents as well as consulting partners to extract critical information pertaining to the syndicated as well as consulting projects. Primary interviews were conducted with the stakeholders across industry verticals at regular intervals in line with the ongoing studies and to keep ourselves abreast with the latest market trends & developments. Validation of the estimated market size, and current and future trends done from the key opinion leaders (KOLs). These KOLs are the CXO level people from leading companies in the industry and possess the experience of around 10-20 years in the industry. On the other hand, the secondary research methodology involves exhaustive desk research undertaken to understand the prevailing market trends & dynamics, market competition, customer insights and other KPIs. Company websites, their SEC filings, annual reports, broker & financial reports and investor presentations are scanned for understanding the competitive scenario, details and developments, and the overall competitive landscape. Regional government and statistical databases were analyzed for macro & microanalysis. Research publications and paid data are referred to obtain and validate the market estimations, budget, expenditure, and other statistical insights.

Multiple recurrent waves of COVID-19 resulted in major fluctuations in blood supply and demand, posing a significant challenge for blood centers to maintain adequate blood inventory. At the same time, increased blood wastage, due to blood unit outdating caused by the COVID-19 outbreak was also recorded.

Key Takeaways from the Study:

  • In terms of Type, the Blood Bank Management Software Market is segmented into Blood Donor Management Module, Blood Bank Transfusion Service Module, and Others. Blood Bank Transfusion Service Module is expected to dominate the market in 2022, as it enhances patient safety by automating and standardizing transfusion processes, reducing the risk of errors, and ensuring appropriate blood product administration. It improves the efficiency of transfusion services, streamlines documentation, and supports regulatory compliance, by providing accurate and real-time information. It helps healthcare professionals make informed decisions and deliver timely and effective transfusion therapy.

  • On the basis of Deployment Mode, the Blood Bank Management Software Market is segmented into on-premise and cloud-based. The cloud-based segment is expected to hold a substantial share of the market during the forecast due to the streamlining and automating activities including blood donation, inventory management, testing & screening, blood product delivery, and reporting.

  • Based on End-User, the Blood Bank Management Software Market is segmented into Standalone Blood Banks and Hospital-based Blood Banks. The Hospital-based Blood Banks segment is expected to dominate the market in 2022. It implies a unit inside a hospital that stores and disperses as well as performs compatibility tests on, blood and blood components solely for utilization inside hospitals, counting hospital-based transfusion exercises.

Report Scope:

Report Metric

Details

Market Value in 2022

US$ 602.19 Million

Market Growth Rate (from 2015 to 2030)

5.2%

Historical Data

2016-2021

Base Year

2022

Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By type, by deployment mode, by end-user

Key Companies Profiled

Haemonetics Corporation, Orchard Software Corporation, Soft Computer Consultants, Inc., CompuGroup Medical, Oracle (Cerner Corporation), TECHNIDATA, WellSky, Mak-System, Strides Software Solutions, and Integrated Medical Systems

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.

Target Audience:

  • Supply-side:

  • Demand Side: Government Agencies, Consulting Firms, Private Research and Development Firms, Equity Firms, and Investment Firms.